Acquisition of scientific infrastructure. The platform is designed for clinical‑grade cell processing and will enable immunomagnetic separation of different cell types, their genetic manipulation, and their expansion and culture — all within the same equipment. Specifically, the aim is to obtain haematopoietic progenitor cells (CD34+) and lymphocytes through apheresis using a magnetically activated cell sorting (MACS) system. This system employs antibody‑conjugated particles containing iron, which can be retained or released by applying or interrupting a magnetic field. After several automated washing steps, most of the liquid is removed, and the selected cells are subsequently eluted from the column once the magnetic field is turned off.
Project reference number: IFEQ21/00201
Brief description of the objective or purpose of the grant:
Principal Investigator: Óscar Moreno Pérez
Funding entity: Carlos III Health Institute
Call: Acquisition of Scientific‑Technical Equipment and Infrastructure 2021
From: 01/01/2022
To: 31/12/2023
Grant awarded: 212.000,00 €
